Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies
Main Authors: | Bays, Harold E., Ballantyne, Christie M., Braeckman, Rene A., Stirtan, William G., Soni, Paresh N. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer International Publishing AG
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572383/ |
Similar Items
-
Effect of Concomitant Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on the Pharmacokinetics of Atorvastatin
by: Braeckman, Rene A., et al.
Published: (2014) -
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Pharmacokinetic Parameters of Rosiglitazone in Healthy Subjects
by: Braeckman, Rene A, et al.
Published: (2015) -
Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults
by: Braeckman, Rene A., et al.
Published: (2014) -
Pharmacokinetics of Eicosapentaenoic Acid in Plasma and Red Blood Cells After Multiple Oral Dosing With Icosapent Ethyl in Healthy Subjects
by: Braeckman, Rene A, et al.
Published: (2014) -
Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
by: Brinton, Eliot A, et al.
Published: (2013)